Search - tctmd.com

Displaying 221 - 240 of 740

Sort: Relevancy | Date

News Daily News

Post-ACS Patients With Low LDL Levels Remain at Risk: IMPROVE-IT

Michael O'Riordan

October 04, 2021

News Daily News

Women Stand to Gain the Most From Standardized STEMI Protocols

Michael O'Riordan

September 30, 2021

News Daily News

Early Menopause Linked to Increased ASCVD Risk

L.A. McKeown

September 17, 2021

News Daily News

CMS Pays More to Male Cardiologists, but the Reasons Why Are Murky

Michael O'Riordan

September 10, 2021

News Daily News

For Young Adults, Cannabis Tied to Doubling of MI Risk

Caitlin E. Cox

September 08, 2021

News Conference News ESC 2021

No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER

Michael O'Riordan

September 02, 2021

News Daily News

Plant-Based Diets Protective Against CVD in Two Studies

L.A. McKeown

August 09, 2021

News Conference News SCCT 2021

As New Guidelines Loom, CT Community Seeks to Fill Knowledge Gaps

Yael L. Maxwell

July 20, 2021

News Daily News

Making the Case for Sex-Specific CVD Guidelines

L.A. McKeown

July 08, 2021

News Daily News

High-Deductible Insurance May Deter ED Visits for Chest Pain

Caitlin E. Cox

July 02, 2021

News Daily News

Delays at Every Stage of STEMI Add Up to Worse Care for Women

L.A. McKeown

June 25, 2021

News Daily News

LDL Cholesterol-Lowering Meds Rarely Intensified: GOULD

Michael O'Riordan

June 18, 2021

News Daily News

First PCIs Preceded by Many Modifiable Risk Factors: Registry Data

L.A. McKeown

June 16, 2021

News Conference News ACC 2021

Global STEMI Initiative Helps Low- and Middle-Income Countries Achieve Better Metrics

L.A. McKeown

May 24, 2021

News Conference News ACC 2021

Clopidogrel, Not Aspirin, for Post-DAPT Monotherapy After PCI: HOST-EXAM

L.A. McKeown

May 16, 2021

News Conference News ACC 2021

Ticagrelor Monotherapy’s Benefits Extend to Women in TWILIGHT

Yael L. Maxwell

May 15, 2021

News Conference News ACC 2021

PARADISE-MI: ARNI Doesn’t Surpass ACE Inhibitor After Acute MI

L.A. McKeown

May 15, 2021

News Conference News ACC 2021

High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE

Michael O'Riordan

May 15, 2021

News Conference News ACC 2021

For Younger MI Survivors, Stress Boosts Adverse Outcomes

Caitlin E. Cox

May 13, 2021

News Conference News ACC 2021

Even With Stent Cards, Patients Often Hazy on PCI Details Years Later

Michael O'Riordan

May 11, 2021

Advertisement

Post-ACS Patients With Low LDL Levels Remain at Risk: IMPROVE-IT

Women Stand to Gain the Most From Standardized STEMI Protocols

Early Menopause Linked to Increased ASCVD Risk

CMS Pays More to Male Cardiologists, but the Reasons Why Are Murky

For Young Adults, Cannabis Tied to Doubling of MI Risk

No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER

Plant-Based Diets Protective Against CVD in Two Studies

As New Guidelines Loom, CT Community Seeks to Fill Knowledge Gaps

Making the Case for Sex-Specific CVD Guidelines

High-Deductible Insurance May Deter ED Visits for Chest Pain

Delays at Every Stage of STEMI Add Up to Worse Care for Women

LDL Cholesterol-Lowering Meds Rarely Intensified: GOULD

First PCIs Preceded by Many Modifiable Risk Factors: Registry Data

Global STEMI Initiative Helps Low- and Middle-Income Countries Achieve Better Metrics

Clopidogrel, Not Aspirin, for Post-DAPT Monotherapy After PCI: HOST-EXAM

Ticagrelor Monotherapy’s Benefits Extend to Women in TWILIGHT

PARADISE-MI: ARNI Doesn’t Surpass ACE Inhibitor After Acute MI

High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE

For Younger MI Survivors, Stress Boosts Adverse Outcomes

Even With Stent Cards, Patients Often Hazy on PCI Details Years Later

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content